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PREVIOUS studies on the localization of fluorene-2,7-di-(sulfonamido-2-
naphthalene)-S35 revealed that the presence of a subcutaneously transplanted
tumor decreased the uptake of this radioactive compound by the liver and spleen
of mice (Argus and Hewson, 1954; Argus, Hewson and Ray, 1956). This
phenomenon was demonstrated in both CAF1/Jax mice bearing a squamous
cell stomach carcinoma and C3H mice bearing the Barrett mammary adeno-
carcinoma. Autoradiograms indicated that it is a phagocytic function of the
reticuloendothelial system that is impaired (Argus, Hewson and Ray, 1956).
Subsequent studies to determine if other stress conditions produce this pheno-
menon showed that, unlike the presence of a tumor, neither X-irradiation nor
cortisone affects the uptake of fluorene-2,7-di-(sulfonamido-2-naphthalene)-S35
by the liver and spleen of mice or rats (Argus, Kane and Ray, 1960; Malejka,
Argus and Ray, 1961).
In the present studies this localization phenomenon was investigated in
hamsters and rats as influenced by the presence of two different types of trans-
planted tumors (a fibrosarcoma and Walker carcinosarcoma 256). The effect
ofmetastatic tumors existing after surgical removal of the transplanted sarcoma
was studied in hamsters, and the effects of liver regeneration (resulting from
partial hepatectomy) and of pregnancy were observed in rats. To determine
if the phenomenon occurs as a result of the increase in proliferation of liver cells
(Laird and Barton, 1959, 1960) caused by the carcinogen, 2-acetylaminofluorene,
before the gross appearance of tumors, the uptake of fluorene-2,7-di-(sulfona-
mido-2-naphthalene)-S35 by the liver and spleen of rats fed the carcinogen, 2-
acetylaminofluorene, for varying periods of time was investigated.
MATERIALS AND METHODS
Fluorene-2,7-di-(sulfonamido-2-naphthalene)-S35 having a specific activity
of 13,400 disintegrations/sec./mg. (0-36 /ac/mg.) was prepared as previously
reported (Argus and Hewson, 1954). For administration, the radioactive com-
pound was dissolved (9 mg./ml.) in 0 05N NaOH except for a study of two groups
of hamsters where the injection medium was dilute sodium bicarbonate and
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ethanol (18 mg. compound/ml.). Each rat received 12 mg. of radioactive com-
pound via tail vein. Each hamster received 9 mg. of labeled compound. Ad-
ministration was via the femoral vein except in one study where administration
was intraperitoneally.
A total of 19 female golden hamsters was employed. These animals were 16
weeks old at the beginning ofthe experiment. Six animals received no treatment
before receiving fluorene-2,7-di-(sulfonamido-2-naphthalene)-S35 and served as
controls (Groups I, III and VIII). Eleven hamsters received a subaxillary transplant of a metastasizing fibrosarcoma. This represented the thirteenth
generation transplant of this tumour which originally arose spontaneously and
was recently described by Klein (1961). When the tumor was 4 weeks old and
had reached an average size of 3-2 g. the labeled compound was administered to
7 of these tumor-bearing hamsters (Groups II, IV and IX), while the tumor was surgically removed, under nembutal anesthesia, from 2 others (Group VI). The
tumor was allowed to persist 10 weeks in 2 hamsters, at which time it had reached
an average weight of 7-8 g. and was surgically removed (Group VII). Two addi-
tional animals were subjected to nembutal anesthesia and surgical manipulation
similar to the tumor excision procedure (Group V). These sham operated controls,
as well as those hamsters undergoing tumor excision, were allowed to recover
4 weeks before administration of the fluorene-2, 7-di-(sulfonamido-2-naphthalene)-
S35.
A total of 83 (24 male, 59 female) Wistar rats (Carworth Farms, New City,
New York, U.S.A.) were used. The females for the pregnancy study were 5 to
6 months old; all other rats were 5 to 8 weeks old at the beginning of the experi-
ments. Seven males and 5 females received the radioactive compound without
prior treatment, and these served as controls for the transplanted tumor, 2-
acetylaminofluorene feeding and pregnancy studies. The Walker carcino-
sarcoma 256 was transplanted to the subaxillary region of 2 males and 7 females.
Fluorene-2,7-di-(sulfonamido-2-naphthalene)-S35 was administered to these rats
when the tumor was 10 days old and had an average weight of 5-7 g. Fifteen
male rats received, by stomach tube, 2-acetylaminofluorene suspended in 1
per cent methylcellulose. The dosage of carcinogen was 3 mg. daily, five times
weekly for 20 weeks. The sulphur-35 localization study was carried out in groups
of 2 or 3 animals at intervals of 4, 6, 11, 14, 22, 29 and 33 weeks following the first
ingestion of 2-acetylaminofluorene. The 9 ratsused in the pregnancy study were
bred at the Carworth Farms and the exact date of conception was supplied with
the animals. The radioactivity localization study was carried out in groups of
2 or 3 of these rats at 6, 10, 15 and 19 days after conception. At autopsy each
rat used in this study had 10 to 12 fetuses. Partial hepatectomy, performed on
34 female rats, involved removal of two-thirds of the liver under nembutal
anesthesia. Groups of 4 or 5 of these rats were administered the radioactive
compound at 0, 6, 18, 24, 42, 66, 90, 114 and 234 hour intervals following partial
hepatectomy. Four female rats, which served as the sham operated controls
for the partial hepatectomy study, were subjected to nembutal anesthesia,
abdominal incision and liver massage immediately before administration of
fluorene-2, 7-di-(sulfonamido-2-naphthalene)-S35.
Following adminstration of the radioactive compound, each animal was
placed in an individual metabolism cage. Hamsters were killed at 8 hours and
rats at 6 hours following administration of the radioactive compound. The
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concentration and per cent recovery of radioactive material in the tissues and
excreta were determinedbymethodspreviously described (Argus, Seepe, Gutierrez,
Hewson and Ray, 1958). The localization of radioactivity was determined in
total fetal tissue at 10, 15 and 19 days in the pregnancy studies. Following
intraperitoneal administration of fluorene-2, 7-di-(sulfonamido-2-naphthalene)-S35
to hamsters, the radioactivity remaining in the peritoneal cavity was determined
on an aliquot of fluid obtained from four washinlgs ofthis cavity with 10 ml. por-
tions of distilled water before removal of the organs. Total blood volume for
rats and hamsters was calculated on the basis of 6-7 ml. blood per 100 g. body
weight (Cartland and Koch, 1928).
RESULTS AND DISCUSSION
The tissue distribution of radioactivity in hamsters following injection of
fluorene-2, 7-di-(sulfonamido-2-naphthalene)-S35 is given in Table I. Comparisons
ofthe uptake ofradioactivity by the liver and spleen oftumor-bearing and tumor-
free hamsters are presented in Table II. These are expressed as ratios in the
same manner as was used previously in similar studies with mice (Argus Hewson
and Ray, 1956). In Groups I and II the radioactive compound was administered
intravenously in a dilute bicarbonate and ethanol solution. This permitted
direct comparison with the results from our previous studies with this compound
in mice where the same injection medium was employed (Argus and Hewson,
1954; Argus, Hewson and Ray, 1956). The ratio values comparing Group I
and Group II (Table II) show that the liver tissue oftumor-free hamsters localizes
1*85 times as much radioactivity as the liver from tumor-bearing hamsters;
this ratio for the spleen is 1-80. As can be seen from the range values for Groups
I and II on Table II there is no overlapping of concentration values for either
organ between control and experimental animals.
Thus, the phenomenon of decreased uptake for fluorene-2, 7-di-(sulfonamido-
2-naphthalene)-S35 by the liver and spleen of tumor-bearing animals as compared
to tumor-free animals was demonstrated in hamsters with a transplanted fibro-
sarcoma. In these and previous experiments it was difficult to maintain the
radioactive compound in a uniform concentration in the injection medium.
Fluorene-2, 7-di-(sulfonamido-2-naphthalene)-S35 is soluble in 0-05 N NaOH, and
the above experiment was repeated using this injection medium (Groups III and
IV, Tables I and II). The ratio values were again significantly greater than 1*00,
and, thus, 005 NNaOH was selected asthe solvent forthe subsequent experiments.
It was next attempted to demonstrate this phenomenon with metastatic
tumors. For these studies the transplanted fibrosarcoma was completely excised
at 4 weeks (Group VI) or at 10 weeks (Group VII). When the animals were
killed, 4 weeks after excision, metastatic tumors of the lung and kidney were
grossly evident in the hamsters of Group VII. Although metastatic tumors
were not visible grossly in the animals of Group VI, Klein (1961) reported 73
per cent metastasis with this tumor following excision of the primary tumor at
4 weeks when there was no recurrence ofthe primary tumor and the animals were
killed 13 weeks after excision of the transplanted fibrosarcoma. Sham operated
hamsters (Group V) served as controls for the experimental animals of Groups
VI and VII.
Comparing control Groups III and V it is evident that there is an increased
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TABLE I.-Distribution of Radioactivity in Female Golden Hamsters at 8 Hours
Following Intravenous or Intraperitoneal Injection ofFluorene-2, 7-Di-(Sulfonamido-
2-Napthalene)-S35
Concentration in ,pg. compound per g. tissue, or ml. blood cells or plasma
*Group Group Group Group Group Group Group Group Group
I II III IV V VI VII VIII IX
Blood cells . . 8 34 9 6 4 11 4 3 1
Blood plasma . . 18 52 12 9 19 22 25 11 5
Liver . . . . 616 333 215 152 713 265 258 126 163
Lungs . . . 157 147 126 92 163 134 168 45 61
Spleen . . . 117 65 38 20 65 49 67 195 57
Kidney . . . . 93 94 83 62 27 113 118 29 43
Skin . . . . 34 34 37 25 43 52 28 13 24
Leg muscle . . 43 46 62 32 54 164 126 8 21
Stomach with contents . 57 133 32 42 45 108 60 70 30
Smallintestine with contents 156 119 177 80 172 179 75 333 142
Large intestinewith contents 689 792 579 693 174 654 329 348 435
Carcass . . . 45 49 39 38 63 86 45 75 48
Tumour. . . 44 57 - 15
Excreta . . . . 422 35 46 8 543 193 1458 28 34
Abdominalfluid 45 63
Percentage administered radioactivity recovered
* Group Group Group Group Group Group Group Group Group
I II III IV V VI VII VIII IX
Blood cells . . 0-31 0-56 0-31 0 39 0 13 0 35 0.15 0.13 0 05
Blood plasma . . . 069 1-89 0 43 0 42 0 68 0 74 0 45 0 45 0 27
Liver . . . . 20-63 13-40 8 86 7 99 26-38 9 92 10-77 6-83 9 80
Lungs . . . 099 1-05 074 0-74 1-16 0-85 1-62 0*43 0*45
Spleen . . . . 014 012 005 0.05 0-10 0 07 0-12 0-23 0-18
Kidney . . 0-91 0-96 0-89 0-67 0-34 1-17 118 0-31 0-54
Skin . . . 8-26 8-03 8-45 6-72 9*04 8-85 5-64 2-88 6-64
Leg muscle . . . 0.25 0-42 0 57 0 31 0-34 1-74 1 09 0 08 0 37
Stomach with contents . 1-53 0 69 0-85 076 1-03 2*39 1-25 1-72 0-83
SInall intestinewithcontents 3-26 2-25 4-06 0-76 3-42 3-53 1-35 9 94 4-44
Large intestine with contents 40 89 43 70 35-75 48 09 8 69 41-48 21-95 23-81 36-26
Carcass . . . . 27.03 26-54 35 81 26 57 34-62 41-84 29-23 48-64 36-32
Tumour . . . . 2<12 2-44 - - 0-72
Excreta . . . . 3-53 059 0-48 0-08 5-98 2-09 16-12 0-31 0-38
Abdominal fluid . . - 3-79 3-55
Total . 108-42 102-32 97-25 95-99 91 91 115-02 90 92 99 55 100-80
* Group I-Controls, injected i.v., compound in dilute sodium bicarbonate and ethanol, average
values from 2 animals.
Group II-Bearing transplanted sarcoma 4 weeks, injected i.v., compound in dilute sodium bi-
carbonate and ethanol, average values from 3 animals.
Group III-Controls, injected i.v., compound in 0. 05N NaOH, average values from 2 animals.
Group IV-Bearing transplanted sarcoma 4 weeks, injected i.v., compound in 0- 05N NaOH, one
animal.
Group V-Sham operated controls, injected i.v., compound in 0-05N NaOH, average values
from 2 animals.
Group VI-Transplanted sarcoma excised at 4 weeks, injected i.v., compound in 0-05N NaOH,
average values from 2 animals.
Group VII-Transplanted sarcoma excised at 10 weeks, injected i.v., compound in 0 05N NaOH,
average values from 2 aminals.
Group VIII-Controls, injected i.p., compound in 0 05N NaOH, average value from 2 animals.
Group IX-Bearing transplanted sarcoma 4 weeks, injected i.p., compound in 0-05SN NaOH,
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TABLE II.-Comparative Study ofthe Uptake ofRadioactivity by the Liver and Spleen
of Female Golden Hamsters at 8 Hours Following Intravenous or Intraperitoneal
Injection ofFluorene-2, 7-Di-(Sulfonamido-2-Napthalene)-S35
Concentration (,pg. compound per g. tissue)
Liver Spleen
Ratio Ratio
Av. /Av.
Control Experimental control Control Experimental _ _ontrol_
Range Average Range Averagerimental) Range Average Range Average rimentalx
*Group I 613-618 616 83-150 117
1*85 1-80
Group II 250-375 333 55-70 65
Group III 202-228 215 28-48 38
1-41 1.90
Group IV 152 152 20 20
Group V 590-845 713 50-80 65
2-69 1*33
Group VI 232-298 265 39-58 49
Group V 590-845 713 50-80 65
2-76 0-97
Group VII 200-315 258 63-70 67
Group VIII 123-130 126 95-295 195
0*77 3-41
Group IX 140-205 163 50-62 57
* See footnote to Table I.
as a result of the sham operation (Table I). Comparing Group V to Group VI
and Group VII we find that there is a definite decreased ability of the liver to
localize the radioactive compound as a result ofthe presence ofmetastatic tumors
(ratios 2-69 and 2-76 with no overlapping of the control and experimental range
values, Table II). The effect on the spleen, however, is not significant.
The phagocytosis of colloidal gold by the liver and spleen of tumor hosts has
been investigated using the intraperitoneal route of administration (e.g., Stern
and Duwelius, 1960). When intraperitoneal injection was employed in our
studies with fluorene-2, 7-di-(sulfonamido-2-naphthalene)-S35 we found (Table I)
a decrease in the localization of radioactivity in the liver and a very marked
increase in the uptake by the spleen in tumor-free hamsters receiving the com-
pound intraperitoneally (Group VIII) as compared to tumor-free hamsters
injected intravenously (Group III).
It should be pointed out that for the intraperitoneal injection no anesthesia
is necessary, while the hamsters receiving fluorene-2, 7-di-(sulfonamido-2-naphtha-
lene)-S35 intravenously are under nembutal anesthesia, which may play a role
in the noted difference in the distribution ofradioactivity. When tumor-bearing
hamsters receiving the intraperitoneal injection (Group IX) are compared to
Group VIII (TableII), itmaybe seenthatthepresence ofthetransplanted sarcoma
considerably decreases the ability of the spleen to localize radioactivity (ratio =
3.41), while with the liver the effect is one of increased uptake (ratio = 0.77).
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and comparative uptake by the liver and spleen of fluorene-2, 7-di-(sulfonamido-
2-naphthalene)-S35 in Wistar rats was studied in both male and female animals
(Tables III and IV). In all cases the tissues of control female rats (Group X)
localize a larger concentration of the radioactive compound than do the corres-
ponding tissues in the control males (Group XI) This influence of sex on localiza-
TABLE III.-Distribution of Radioactivity at 6 Hours Following Intravenous
Injection ofFluorene-2,7-Di(Sulfonamido-2-Naphthalene)-S35 To Wistar Rats With
and Without a Transplanted Walker Carcinosarcoma 256
Blood cells .
Blood plasma
Liver
Lungs
Spleen
Kidney
Thymus
Skin
Leg muscle
Stomach with contents
Small intestine with contents
Large intestine with contents
Carcass
Tumor
Excreta
Total
Concentration in pg. compound
per g. tissue, or ml. blood cells
or plasma
I-
* Group Group Group Group
x xi xii xiii
4 7 1 5
8 8 6 9
176 142 80 79
168 107 74 210
52 50 21 20
82 56 35 43
50 41 22 27
78 91 40 125
45 34 23 42
48 23 30 13
398 289 174 270
373 346 896 835
51 38 21 45
41 61
16 19 42 972
Percentage administered
radioactivity recovered
{ A- 5~~
Group Group Group Group
x XI XII XIII
0-15 0-32 0-06 0-17
0-32 0-35 0-35 0-35
8-51 9-37 5-11 4-51
1-14 1-79 2-46 0-59
0-17 0-50 0-11 0-30
0-84 0-60 0-42 0-49
0-12 0-10 0-07 0-09
17-54 23-12 19-77 29-01
0-49 0-35 0-26 0-31
0-53 0-37 0 47 0-23
17-33 14-98 9-30 14-65
22-33 20-98 52-74 36-79
31-27 22-20 22-62 21-02
- 3-20 - 3-35
0-11 0-15 1-33 5-91
100-85 98-38 115-07 117-77
* Group X-Female controls, average values from 5 animals.
Group XI-Female tumor-bearing, average values from 7 animals.
Group XII-Male contols, average values from 7 animals
Group XIII-Male tumor-bearing, average values from 2 animals.
TABLE IV.-Comparative Study of the Uptake of Radioactivity by the Liver and
Spleen of Wistar Rats at 6 Hours Following Intravenous Injection of Fluorene-2,
7-Di-(Sulfonamido-2-Naphthalene)-S35
Concentration (p4g. compound per g. tissue)
, A_ -A
Liver
Ratio
( Av.
Control Experimental control /
c I_c - % (AV.expe-\ Range Average Range AveragetrimentalJ
Spleen
, (
Ratio
l Av.\
Control Experimental ( control )
Rang Aveg A (Av. expe-;
Range Average Range Average rimntal/
Group X 148-230 176
Group XI
Group XII 52-175 80
Group XIII
78-190 142
1-24
1-01
45-60 52
33-60 50
13-57 21
70-87 79
* See footnote to Table III.
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tion has also been reported in other studies with this compound in rats (Argus,
Kane and Ray, 1960; Malejka, Argus and Ray, 1961). As evidenced by the
overlapping of range values and the ratios not significantly different from unity
(Table IV), the phenomenon of decreased localization in the liver and spleen,
observed in tumor-bearing mice and hamsters, is not manifest in either sex of this
strain of rat with this transplanted tumor.
The influence ofthe regeneration ofliver tissue resulting from partial hepatec-
tomy does, however, show a definite effect on the phagocytic function ofthe liver
and spleen (Fig. 1). Up to 240 hours following the operation, both these organs
show a reduced ability to localize fluorene-2,7-di-(sulfonamido-2-naphthalene)-S35
since the ratios are always greater than 1 00. The liver and spleen follow the
25 X
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FIG. I.- Effect of partial hepatectomy on the uptake of fluorene-2,7-dli-(sulfonamido-2-naph-
thalene)-S35 by the liver and spleen of rats expressed as the ratio : average concentration of
the sham operated controls over the average concentration of the experimentals. The ratios
are plotted as a function of the time in hours following partial hepatectomy.
same pattern of ratio change with time. This apparent decrease in the phago-
cytic function of the reticuloendothelial system of these organs as a result of
active liver regeneration is in opposition to the data reported by Stern (1960).
He reports an increase in the per cent of injected colloidal gold (per gram
of tissue) phagocytized by the liver of rats at 3, 8 and 16 days following
partial hepatectomy. In these studies Au'98 was administered by intracardiac
injection 24 hours before the partial hepatectomy, and the localization values
obtained were compared to controls undergoing the sham operation at the same
time interval before killing. In our studies, facilities would not permit the sham
operation of groups of animals at each of the time intervals. Thus, all experi-
mental (partially hepatectomized) rats are compared to the same sham operated
controls killed at 6 hours. As reported for the hamsters, sham operation in-
creases the uptake ofradioactivity by the liver and spleen when compared to the
values for these organs from untreated controls. For this reason the ratio values
in Fig. 1 at the later time intervals may be exaggerated since the experimental
rats would have had more time to recover from the effects of the operative pro-UPTAKE OF A RADIOACTIVE COMPOUND
cedures than the controls. However, even if the values for the experimentals
are compared to non-operated control values, the ratios are still greater than
1.00 and indicate consequently a decreased phagocytic function rather than the
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FiG. 2.-Influence of pregnancy on the uptake of fluorene-2,7-di-(sulfonamido-2-naphthalene)
S35 by the liver and spleen of rats expressed as the ratio: average concentration of the
untreated controls over the average concentration of the experimentals. The ratios are
plotted as a function of the days from conception.
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FIG. 3.-Effect of the ingestion of 2-acetylaminofluorene on the uptake of fluorene-2,7-di-
(sulfonamido-2-naphthalene)_S35 by the liver and spleen of rats expressed as the ratio:
average concentration of the untreated controls over the average concentration of the
experimentals. The ratios are plotted as a function of the time in weeks from the first
ingestion of the carcinogen. Feeding of 2-acetylaminofluorene was maintained up to the
20th week.
increased phagocytosis reported by Stern (1960) under his experimental
conditions.
That the presence of developing fetuses also influences the uptake of fluorene-
2, 7-di-(sulfonamido-2-napthalene)-S35 by the liver and spleen is shown in Fig. 2.
The values for the spleen indicate a maximum depression in phagocytosis between
10 and 19 days following conception, while for the liver there is a gradual increase
in the ratio values with time. Low levels of radioactivity were found in the fetal
I
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tissues at 10, 15 and 19 days (average =11 ,ug./g. tissue) indicating that some
fluorene-2,7-di-(sulfonamido-2-naphthalene)-S35 crosses the placental barrier.
The greatest effect on the phagocytic function of the liver and spleen of rats,
as determined by the uptake of fluorene-2,7-di-(sulfonamido-2-naphthalene)-$35,
was found following the ingestion of the potent carcinogen, 2-acetylaminofluorene
(Fig. 3). The general pattern of ratio change is the same for the liver and spleen
with the phenomenon being more pronounced for the liver at all times. The
largest increase in ratio values is evident at 22 weeks. The earliest tumor with
the dietary level of 2-acetylaminofluorene employed here was reported at 29
weeks (Argus and Ray, 1959). In the present study only livers with no gross
evidence of tumors were analyzed. Laird and Barton (1959, 1960) demonstrated
that during the feeding of 2-acetylaminofluorene to rats there is a considerable
increase in the proliferation of liver cells beginning as early as 4 weeks. It is,
therefore, of interest to note that the decrease in localization of fluorene-2, 7-di-
(sulfonamido-2-naphthalene)-S35 is already demonstrable at this time. This
correlates with our previous observations that the presence of various rapidly
growing tissues in the animal body causes impairment ofthis phagocytic function.
SUMMARY
1. The phenomenon of decreased phagocytic function of the liver and spleen,
as measured by the uptake of fluorene-2,7-di-(sulfonamido-2-naphthalene)-SS5,
has been demonstrated with female golden hamsters bearing a transplanted
fibrosarcoma, but not in male or female Wistar rats bearing the transplanted
Walker carcinosarcoma 256.
2. Metastatic tumors arising in hamsters from the fibrosarcoma bring about
a considerable decrease in the uptake of the radioactive compound by the liver,
but not by the spleen.
3. Three experimental situations: partial hepatectomy, pregnancy, and
ingestion of the carcinogen, 2-acetylaminofluorene, each resulted in an impair-
ment ofboth the liver and spleen of rats to localize fluorene-2, 7-di-(sulfonamido-
2-naphthalene)-S35.
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